Target intelligence / Profile preview

Host metabolic pathways

Molecular classification
Other
01

Overview

Host metabolic pathways refer to the complex and interconnected series of biochemical reactions enabling the synthesis (anabolism) and degradation (catabolism) of biomolecules, supplying energy and building blocks required for cell survival, growth, communication, and adaptation. In the context of disease or drug development, "host metabolic pathways" is not a precise molecular target, but rather a category encompassing numerous enzymes, transporters, and metabolic actions within the host cell. These pathways are implicated in disease pathogenesis (e.g., cancer metabolism, infection where pathogens hijack host metabolism), therapeutic intervention, and the modulation of drug efficacy and toxicity. Because of their central role and diversity, targeting host metabolic pathways must be approached with caution to avoid unintended effects on normal physiology. In summary, "host metabolic pathways" is not a conventional, singular drug target, but a broad system comprising many distinct molecules and pathways relevant to health and disease. Therefore, it is not suitable for structured target-level annotations as required for individual receptors, enzymes, or proteins.

Other names
Metabolic pathways (host)Host metabolismCellular metabolic pathwaysEndogenous metabolic pathways
02

Mechanism of action

Enzyme inhibition or activation (e.g., acetyl-CoA carboxylase inhibitors); Modulation of metabolic flux (e.g., AMPK activators); Alteration of substrate availability (e.g., glucose analogs); Targeting host metabolic dependencies of pathogens (host-directed therapy).

03

Biological functions

Energy productionBiosynthesis of macromoleculesCatabolism of nutrientsCellular homeostasisSignal transductionImmune response
04

Disease associations

CancerInfectionMetabolic diseases (e.g., diabetes, obesity)Cardiovascular diseaseInflammationNeurodegenerative disease
05

Safety considerations

Off-target effects due to pathway ubiquityDisruption of essential cellular processesMetabolic toxicity (e.g., lactic acidosis)Potential immunosuppression or dysregulation of homeostasis
06

Interacting drugs

Metformin (modulates host glucose metabolism)

4 more in the full profile.

07

Biomarkers

Blood glucoseLipid profiles (e.g., triglycerides, LDL/HDL cholesterol)LactateAmino acids (e.g., tryptophan)NAD+/NADH ratiosCirculating metabolic products

Beyond the preview

Go deeper on Host metabolic pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host metabolic pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call